H2020Individual fellowship2016–2019

EXACT · Identifying biomarkers of Exposure leading to Lung Cancer with Adductomics

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2016-06-01 → 2019-02-28
EU contribution
€195,455
Participants
1
Scheme
MSCA-IF-EF-ST

Lines connect the coordinator with its partners.

Results in brief

Identifying biomarkers of Exposure leading to Lung Cancer with Adductomics

Lung Cancer (LC) is the leading cause of cancer death worldwide (1.8 million deaths in 2018), the survival of patients is highly depended on accurate and early diagnosis, and current methods are reported to partially result in diagnostic error resulting in treatment delay and decrease of survival rates. Further knowledge is needed to detect early markers of lung cancer and improve understanding of early carcinogenesis. Lung Cancer is known to be causally linked to tobacco smoke and recently air pollution has also been recognized as a lung carcinogen. To understand the mechanisms of LC onset, methods are needed to characterize specific toxicants in tobacco smoke and air pollution that people are exposed to, as well as molecular pathways. Electrophiles present in blood are highly reactive species that have been long suspected of causing cancer and other diseases. These electrophiles enter the organism by direct exposure (inhalation, ingestion) or via internal mechanisms such as metabolism of exogenous compounds, oxidation of lipids, and inflammation associated with prior disease and contribute to oxidative stress. Oxidative stress (OS) has been linked to smoking habits and is known to contribute to carcinogenesis. Reactive oxygen species (ROS) contribute to oxidative stress, causing cell damage, but as they are small and rapidly degraded, they cannot be easily quantified. These highly reactive species have been long suspected of causing cancer and other diseases because of their ability to bind to DNA and proteins. The challenge for their measurement is due to their very short half-life in the body and their high reactivity, which makes them almost impossible to measure. However, it is possible to measure the adducts resulting from their binding to DNA or proteins (Hemoglobin and Albumin). The Cysteine34 (Cys34) locus of the Human Serum Albumin (HSA) represents a preferred reaction site for small electrophilic species. HSA has a long half-life in serum (30 days) and is present at high concentration; therefore, it is a good marker to measure exposure to toxic electrophiles. Up to now, current techniques have focussed on the targeted measure of pre-selected albumin-adducts in serum to detect exposure to certain chemicals. Although targeted assays can relate Cys34 adducts to specific exposures, they are not well suited for discovering unknown causes of human diseases arising from exposures to electrophilic species. In this project, we applied a new method based on high resolution mass spectrometry; this novel approach is based on an agnostic untargeted analysis of known and unknown adducts of albumin and electrophiles to determine oxidative stress. The objectives of EXACT were to (i) Apply agnostic adductomics to a nested case-control study of 250 prospective cases and controls of Lung Cancer (ii) Determine differential adducts profiles in cases and controls years before diagnosis (iii) Relate adduct profiles to exposure data and methylation measurements in order to elucidate biological pathways and exposure leading to lung cancer. Conclusions: For the first time we were able detect, in prospective blood samples, decreased levels of the N-acetylcysteine (NAC) and Cysteine-Glycine adducts in lung cancer cases. Altogether, our results highlight the implications of these adducts in the oxidative stress response contributing to lung cancer years before diagnosis.

Data: CORDIS, © European Union

Project objective

Over 20% of death by cancer in the world are due to Lung Cancer (LC). Tobacco, and recently, exposure to air pollution, are considered the main causes for LC, thus specific carcinogens have been only partially identified. The complex composition of tobacco smoke and air pollution makes it difficult to identify the specific compounds responsible for the carcinogenesis process. To understand the mechanisms of LC onset, methods are needed to characterize specific toxicants that people are exposed to. We propose to develop a new method to identify exposure-specific (tobacco or air pollution) markers of LC. This new method is based on the measure of the ensemble of electrophile-carcinogens and human serum albumin adducts in human serum: the Adductome. Electrophiles present in blood are highly reactive species that have been long suspected of causing cancer because of their ability to bind DNA and proteins. Protein adducts provide more suitable markers of exposure as they have a longer life span in the blood and are present in much higher concentrations, but have been poorly investigated. In EXACT we hypothesise that protein-carcinogen electrophiles adducts can be used as markers of LC carcinogenesis and that different markers can be identified for tobacco-induced or air pollution-induced disease. Our objective is to improve the current analytical methodology for adductomics analysis and develop a new methodology for adducts structural identification in order to characterize adduct profiles in 400 samples of human serum from the EPIC cohort. Statistical analyses will be carried out to link adducts profiles to smoking status, air pollution data and methylation profiles. The elucidation of the markers structure will allow us to establish a database of candidate compounds responsible for the carcinogenicity of tobacco and air pollution. EXACT will serve as a proof of concept to develop a novel technique based on the use of the Adductome to elucidate disease causality.

Original text from CORDIS.

Participants

  • IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE · LondonCoordinatorUnited Kingdom

Links

Data: CORDIS, © European Union